Skip to content

Symptom Trajectories and Influencing Factors in Breast Cancer Patients Treated with Subcutaneous Targeted Agents: A Prospective Longitudinal Study

Symptom Trajectories and Influencing Factors in Breast Cancer Patients Treated with Subcutaneous Targeted Agents: A Prospective Longitudinal Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125473
Enrollment
Unknown
Registered
2026-05-27
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Observation group:None

Sponsors

Tianjin Medical University Cancer Institute & Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: 1. Female gender; 2. Aged 18 to 59 years old; 3. Clinically and pathologically diagnosed with stage I-III breast cancer; 4. Patients scheduled to receive subcutaneous injection of targeted drugs; 5. Capable of completing symptom diaries and telephone follow-up independently or with assistance; 6. Clear consciousness without mental or communication disorders.

Exclusion criteria

Exclusion criteria: 1. Complications such as severe systemic infection, severe anemia or vital organ failure; 2. History of breast cancer or other malignancies within the past 5 years; 3. Distant tumor metastasis.

Design outcomes

Primary

MeasureTime frame
Physical symptoms;Psychological symptoms;Scores of adverse reactions in each dimension of subcutaneous injection of targeted drugs for breast cancer;

Countries

China

Contacts

Public ContactLiu Chunmei

Tianjin Medical University Cancer Institute & Hospital

fish8373@163.com+86 136 0214 4437

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026